Kuehn Law tutkii TG Therapeuticsin johtoa ja hallitusta
Kuehn Law, PLLC aloittaa tutkinnan TG Therapeuticsin johtajien ja hallituksen jäsenten mahdollisista velvollisuusrikkomuksista. Tutkinnassa selvitetään mahdollisia eturistiriitoja.
Shareholder litigation law firm Kuehn Law, PLLC has initiated an investigation into the officers and directors of TG Therapeutics, Inc. (NASDAQ: TGTX), concerning potential breaches of fiduciary duties. The investigation focuses on allegations of self-dealing.
Shareholders who believe they may have been harmed by these actions are encouraged to contact Kuehn Law. The firm stated that affected stockholders who are long-term TGTX investors may be entitled to damages and corporate governance reforms. Details regarding the specific nature of the alleged self-dealing were not disclosed in the initial announcement.
Kuehn Law emphasizes that consultations and case assessments are free and without obligation. The firm stated it covers all case costs, and its investor clients do not incur upfront charges. The firm has not provided details on the timeline of the alleged misconduct or the period under investigation.
The law firm urges shareholders to contact them promptly, noting that there may be limited time to assert their rights. "Your investment. Your voice. Your future." is cited as a reason for shareholder participation. Kuehn Law, PLLC is located in Southampton, NY.